Out of the 24 analysts that have coverage on DLF, 21 of them have a ‘Buy’ rating, while three have a ‘Hold rating. Previous Post Five Years After Covid-19 Lockdown: Nifty 50 stocks that delivered the maximum returns Next Post Biocon unit gets USFDA nod for blood pressure treatment drug Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
